Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response (Q79202325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Rumi Murata

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

1047-1055

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

The Vascularization of Tumors

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Vascular attack as a therapeutic strategy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Factors determining the action of colchicine on tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Vinca alkaloids: anti-vascular effects in a murine tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

The development of combretastatin A4 phosphate as a vascular targeting agent

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Enhancement of radiation therapy by the novel vascular targeting agent ZD6126.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Combination of vascular targeting agents with thermal or radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Regional blood flow by fractional distribution of indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

ZD6126: a novel small molecule vascular targeting agent

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Activity of the vascular targeting agent combretastatin A-4 disodium phosphate in a xenograft model of AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Antitumor efficacy of conventional anticancer drugs is enhanced by the vascular targeting agent ZD6126

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900769-7

7 January 2021

10.1016/S0360-3016(03)00769-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference